Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05605639 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phrenic Nerve Infiltration in Neck Pain

Study acronym: PAINOMICS
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 11, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates: Jul 2024 to Jul 2025v6
  2. Notable Primary and study completion dates: Nov 2023 to Jul 2024
    • Study sites: 1 to 2
    v5
  3. Notable Primary and study completion dates: Mar 2023 to Nov 2023v4
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2022 to Nov 17, 2022
    v3
  5. Minor Eligibility criteria expanded, about 1 word
    • Study description expanded, about 1 word
    v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Neck pain frequently present comorbidities in peridiaphragmatic organs. The innervation of these organs include the phrenic nerve. It is known that peridiaphragmatic organs trigger referred pain in the neck area. As well, previous studies have shown that visceral disorders increase sensitization in somatic tissues. This study aims to analyze the ability of phrenic nerve infiltration to diminish sensitization and improve neck symptoms in the absence of neurological, traumatic or infectious pathology that justifies the pain, by means of a randomized controlled trial.
Trial Details
NCT Number NCT05605639
Lead Sponsor University of Seville
Conditions
(from sponsor)
Chronic Neck Pain
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov